S. Seber - Concepedia

Author

S. Seber

Also Known As

Duygu Bayir, E.S. Seber, Erdogan Selcuk SEBER, Erdogan Selcuk Seber, Erdoğan S. Şeber, Erdoğan Selcuk Seber, Erdoğan Selçuk ŞEBER, Erdoğan Selçuk Şeber, Hakan Harputluoglu, M. J. Davies

100

Publications

798

Citations

H-Index

Concepts

All Affiliations

Tekirdağ Namık Kemal University Şişli Etfal Eğitim ve Araştırma Hastanesi Marmara University Eskişehir Osmangazi University Dokuz Eylül University

About

S. Seber is an author at Tekirdağ Namık Kemal University specializing in medicine, diabetes, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	198
2	Diabetes	3	3	92
3	Health Sciences	1	1	52
4	Endocrinology	1	1	52
5	Family Medicine	1	1	15

S. Seber

Publications

486

Citations

H-Index

Page 1

	Year	Citations
The effect of dual PPAR α/γ stimulation with combination of rosiglitazone and fenofibrate on metabolic parameters in type 2 diabetic patients S. Seber, Sema Uçak, Okcan Basat, Diabetes Research and Clinical Practice Metabolic SyndromeDiabetes ManagementMetabolic ParametersMedicineInsulin Management	2005	52
Combination of Pentoxifylline with Angiotensin Converting Enzyme Inhibitors Produces an Additional Reduction in Microalbuminuria in Hypertensive Type 2 Diabetic Patients Özlem Harmankaya, S. Seber, Mürvet Yılmaz Renal Failure	2003	52
Protective effects of onion (<i>Allium cepa</i>) extract against doxorubicin-induced hepatotoxicity in rats Rafet Mete, Mustafa Oran, Birol Topçu, Toxicology and Industrial Health	2013	43
Recurrent pericarditis as the initial manifestation of Familial Mediterranean fever. Kerem Okutur, S. Seber, Erkan Öztekın, PubMed	2008	40
Visceral Adipose Tissue as an Indicator of Insulin Resistance in Nonobese Patients with New Onset Type 2 Diabetes Mellitus Okcan Basat, Sema Uçak, H. Ozkurt, Experimental and Clinical Endocrinology & Diabetes	2006	28
After myocardial infarction carvedilol improves insulin resistance compared to metoprolol Okcan Basat, Sema Uçak, S. Seber, Clinical Research in Cardiology Metabolic SyndromeCardiovascular DiseaseMedicineInsulin ManagementDiabetes	2006	25
Prospective comparison of the value of CARG, G8, and VES-13 toxicity tools in predicting chemotherapy-related toxicity in older Turkish patients with cancer Eyyüp Çavdar, Yakup İriağaç, Kubilay Karaboyun, Journal of Geriatric Oncology Ves-13 Toxicity ToolsMedicineCancer ManagementPharmacologyProspective Comparison	2022	24
Prevention of heterotopic ossification after total hip replacement: A prospective comparison of indomethacin and salmon calcitonin in 60 patients İzge Günal, Bülent Hazer, S. Seber, Acta Orthopaedica Scandinavica Salmon CalcitoninBone DiseaseHip ArthroplastyOsteopathyProspective Consecutive Study	2001	23
Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis Taner Korkmaz, S. Seber, Umut Kefeli, Clinical & Translational Oncology MedicineCancer ManagementRetrospective AnalysisOutcomes ResearchBronchial Neoplasm	2012	22
Clinical outcome of breast cancer patients with N3a (≥10 positive lymph nodes) disease: has it changed over years? Gül Başaran, Devrim Cabuk, Hale Başak Çağlar, Medical Oncology Breast OncologyBreast Cancer PatientsMedicineCancer ManagementPathology	2010	21

Page 1